Browsing by Author Mezquita, Betlem
Showing results 1 to 1 of 1
| Issue Date | Title | Author(s) |
|---|---|---|
| 21-Aug-2024 | FDA-approved antivirals ledipasvir and daclatasvir downregulate the Src-EPHA2-Akt oncogenic pathway in colorectal and triple-negative breast cancer cells. | Mezquita, Betlem; Reyes, Majorie; Pons Vallès, Miquel |